ARIAD PHARMACEUTICALS
ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.
ARIAD PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1991-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ariad.com
Total Employee:
251+
Status:
Closed
Contact:
(617)494-0400
Email Addresses:
[email protected]
Total Funding:
88.5 M USD
Technology used in webpage:
SSL By Default Domain Not Resolving Amazon Amazon Virginia Region Apache 2.4 Pound Sterling Ubuntu ASP.NET 2.0 TinyMCE Tiny MCE
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:ARIA
Investors List
Credit Suisse
Credit Suisse investment in Post-IPO Equity - ARIAD Pharmaceuticals
Merlin Biomed
Merlin Biomed investment in Post-IPO Equity - ARIAD Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-06-29 | Theseus Pharmaceuticals | ARIAD Pharmaceuticals investment in Series A - Theseus Pharmaceuticals | 20 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer |
